Medigen Vaccine Return On Asset vs. Return On Equity
| 6547 Stock | TWD 34.35 1.10 3.10% |
For Medigen Vaccine profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Medigen Vaccine to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Medigen Vaccine Biologics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Medigen Vaccine's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Medigen Vaccine Biologics over time as well as its relative position and ranking within its peers.
Medigen |
Medigen Vaccine Biologics Return On Equity vs. Return On Asset Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Medigen Vaccine's current stock value. Our valuation model uses many indicators to compare Medigen Vaccine value to that of its competitors to determine the firm's financial worth. Medigen Vaccine Biologics is number one stock in return on asset category among its peers. It also is number one stock in return on equity category among its peers reporting about 3.17 of Return On Equity per Return On Asset. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medigen Vaccine's earnings, one of the primary drivers of an investment's value.Medigen Return On Equity vs. Return On Asset
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Medigen Vaccine |
| = | 0.0209 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Medigen Vaccine |
| = | 0.0662 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Medigen Return On Equity Comparison
Medigen Vaccine is currently under evaluation in return on equity category among its peers.
Medigen Vaccine Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Medigen Vaccine, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Medigen Vaccine will eventually generate negative long term returns. The profitability progress is the general direction of Medigen Vaccine's change in net profit over the period of time. It can combine multiple indicators of Medigen Vaccine, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Medigen Vaccine Biologics Corporation, a biotechnology drug company, focuses on the development and production of vaccines and biologics in Taiwan and internationally. Medigen Vaccine Biologics Corporation is a subsidiary of Medigen Biotechnology Corp. MEDIGEN VACCINE operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange.
Medigen Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Medigen Vaccine. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Medigen Vaccine position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Medigen Vaccine's important profitability drivers and their relationship over time.
Use Medigen Vaccine in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medigen Vaccine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Vaccine will appreciate offsetting losses from the drop in the long position's value.Medigen Vaccine Pair Trading
Medigen Vaccine Biologics Pair Trading Analysis
The ability to find closely correlated positions to Medigen Vaccine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medigen Vaccine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medigen Vaccine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medigen Vaccine Biologics to buy it.
The correlation of Medigen Vaccine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medigen Vaccine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medigen Vaccine Biologics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medigen Vaccine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Medigen Vaccine position
In addition to having Medigen Vaccine in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Recreation Thematic Idea Now
Recreation
Companies involved in production and services of recreational goods, foods, and accessories. The Recreation theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Recreation Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Medigen Stock Analysis
When running Medigen Vaccine's price analysis, check to measure Medigen Vaccine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medigen Vaccine is operating at the current time. Most of Medigen Vaccine's value examination focuses on studying past and present price action to predict the probability of Medigen Vaccine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medigen Vaccine's price. Additionally, you may evaluate how the addition of Medigen Vaccine to your portfolios can decrease your overall portfolio volatility.